Add-on Therapy for Symptomatic Asthma despite Long-Acting Beta-Agonists/Inhaled Corticosteroid

Tuberc Respir Dis. 2017;80:e18. English.
Published online Dec 13, 2017.  https://doi.org/10.4046/trd.2017.0102 

Michael Dreher, M.D. and Tobias Müller, M.D

 

Abstract

Asthma, remains symptomatic despite ongoing treatment with high doses of inhaled corticosteroids (ICS) in conjunction with long-acting beta-agonists (LABA), is classified as “severe” asthma. In the course of caring for those patients diagnosed with severe asthma, stepping up from ICS/LABA to more aggressive therapeutic measures would be justified, though several aspects have to be checked in advance (including inhaler technique, adherence to therapy, and possible associated comorbidities). That accomplished, it would be advisable to step up care in accordance with the Global Initiative for Asthma (GINA) recommendations. Possible strategies include the addition of a leukotriene receptor antagonist or tiotropium (to the treatment regimen). The latter has been shown to be effective in the management of several subgroups of asthma. Oral corticosteroids have commonly been used for the treatment of patients with severe asthma in the past; however, the use of oral corticosteroids is commonly associated with corticosteroid-related adverse events and comorbidities. Therefore, according to GINA 2017 these patients should be referred to experts who specialize in the treatment of severe asthma to check further therapeutic options including biologics before starting treatment with oral corticosteroids.

Formats:

(You must be logged in to add and reply comments)

Interasma on Twitter

Interasma RT @Aller_MD: Top story: @MatthewBowdish: 'Castro: Site of action of targeted therapies for s… https://t.co/M5derssa15, see more https://t.…
2hreplyretweetfavorite
Interasma RT @Aller_MD: “Regeneron (REGN) Reports Approval of DUPIXENT in Japan for Treatment of Atopic Dermatitis” https://t.co/kUdtuobA6v https://t…
2hreplyretweetfavorite
Interasma RT @Aller_MD: Bilastine Newsletter - Discover what´s new in allergy and antihistamines https://t.co/GmJQkUOBIO https://t.co/5pz0xYFzYJ
5hreplyretweetfavorite
Interasma RT @Aller_MD: “Guideline: Experts recommend a single dose of oral steroids for pain relief in acute sore throat” https://t.co/DnEFi1FiCX ht…
5hreplyretweetfavorite
Interasma RT @Aller_MD: Beneficial bacteria on the skin of mice promotes immunity and accelerates wound healing https://t.co/XNFdTCZvsi
5hreplyretweetfavorite

Editor: Juan C. Ivancevich, MD

Copyright © Interasma 2003-2017  •  Terms of Use  •  Privacy Policy  •  Contact Us  •  Sitemap

Powered by FREI SA

InterAsma